NeuroSigma Announces FDA Clearance of its Second-Generation

LOS ANGELES, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NeuroSigma today announced that the U.S. Food and Drug Administration (FDA) cleared use of NeuroSigma’s...

Related Keywords

United States ,London ,City Of ,United Kingdom ,China ,Singapore ,California ,C Thomas Paschall ,Colin Kealey ,Los Angeles ,Checkmate Capital Group ,Drug Administration ,King College London ,Seattle Children ,College London ,Checkmate Capital ,Neurosigma ,Nc ,Adhd ,Neurological ,Onarch Etns ,Onarch 2 0 ,Bioelectronics ,Biotechnology ,Biotech ,